Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.
4.

Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin.

Tarui T, Majumdar M, Miles LA, Ruf W, Takada Y.

J Biol Chem. 2002 Sep 13;277(37):33564-70.

5.

Angiostatin induces mitotic cell death of proliferating endothelial cells.

Hari D, Beckett MA, Sukhatme VP, Dhanabal M, Nodzenski E, Lu H, Mauceri HJ, Kufe DW, Weichselbaum RR.

Mol Cell Biol Res Commun. 2000 May;3(5):277-82.

PMID:
10964751
6.

Multiple forms of angiostatin induce apoptosis in endothelial cells.

Lucas R, Holmgren L, Garcia I, Jimenez B, Mandriota SJ, Borlat F, Sim BK, Wu Z, Grau GE, Shing Y, Soff GA, Bouck N, Pepper MS.

Blood. 1998 Dec 15;92(12):4730-41.

7.

Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.

Brauer R, Beck IM, Roderfeld M, Roeb E, Sedlacek R.

BMC Biochem. 2011 Jul 25;12:38. doi: 10.1186/1471-2091-12-38.

8.

Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance.

O'Reilly MS, Wiederschain D, Stetler-Stevenson WG, Folkman J, Moses MA.

J Biol Chem. 1999 Oct 8;274(41):29568-71.

9.

Endothelial progenitor cells as putative targets for angiostatin.

Ito H, Rovira II, Bloom ML, Takeda K, Ferrans VJ, Quyyumi AA, Finkel T.

Cancer Res. 1999 Dec 1;59(23):5875-7.

10.

Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells.

Hanford HA, Wong CA, Kassan H, Cundiff DL, Chandel N, Underwood S, Mitchell CA, Soff GA.

Cancer Res. 2003 Jul 15;63(14):4275-80.

11.

Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.

Ji WR, Castellino FJ, Chang Y, Deford ME, Gray H, Villarreal X, Kondri ME, Marti DN, LlinĂ¡s M, Schaller J, Kramer RA, Trail PA.

FASEB J. 1998 Dec;12(15):1731-8.

PMID:
9837863
12.

Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.

Tuszynski GP, Sharma MR, Rothman VL, Sharma MC.

Microvasc Res. 2002 Nov;64(3):448-62.

PMID:
12453439
13.
14.

Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis.

Benelli R, Morini M, Brigati C, Noonan DM, Albini A.

Int J Oncol. 2003 Jan;22(1):87-91.

PMID:
12469189
15.
16.

Angiostatin: a negative regulator of endothelial-dependent vasodilation.

Koshida R, Ou J, Matsunaga T, Chilian WM, Oldham KT, Ackerman AW, Pritchard KA Jr.

Circulation. 2003 Feb 18;107(6):803-6.

17.

Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin.

Moser TL, Kenan DJ, Ashley TA, Roy JA, Goodman MD, Misra UK, Cheek DJ, Pizzo SV.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6656-61.

18.

Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells.

Tarui T, Miles LA, Takada Y.

J Biol Chem. 2001 Oct 26;276(43):39562-8.

19.

Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen.

Falcone DJ, Khan KM, Layne T, Fernandes L.

J Biol Chem. 1998 Nov 20;273(47):31480-5.

20.

Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.

Stack MS, Gately S, Bafetti LM, Enghild JJ, Soff GA.

Biochem J. 1999 May 15;340 ( Pt 1):77-84.

Supplemental Content

Support Center